Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
暂无分享,去创建一个
M. Goris | M. Tempero | G. Adams | L. Weiner | S. Knox | D. Fisher | I. Horak | P. Weiden | D. Colcher | D. Colcher | H. Breitz | D. Axworthy | K. Bryan | L. Gentner | S. Gaffigan | Sally Gaffigan | Lou Gentner